CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-02 | NELSEN ROBERT Director | Grant or award | +2,074 | 12,432 | ||
| 2021-06-02 | NELSEN ROBERT Director | Grant or award · Stock Option (right to buy) | +6,222 | 6,222 | ||
| 2021-06-01 | NELSEN ROBERT Director | Option exercise | +3,253 | 10,358 | ||
| 2021-06-01 | NELSEN ROBERT Director | Option exercise · Restricted Stock Units | −3,253 | 0 | ||
| 2021-05-12 | NELSEN ROBERT Director | Other disposition | −500,000 | 9,668,749 | ||
| 2021-05-12 | NELSEN ROBERT Director | Other acquisition | +2,537 | 7,105 | ||
| 2021-03-22 | NELSEN ROBERT Director | Other disposition | −500,000 | 10,168,749 | ||
| 2021-03-22 | NELSEN ROBERT Director | Other acquisition | +2,538 | 4,568 | ||
| 2020-06-03 | NELSEN ROBERT Director | Grant or award · Stock Option (right to buy) | +15,183 | 15,183 | ||
| 2020-06-03 | NELSEN ROBERT Director | Grant or award · Restricted Stock Units | +3,253 | 3,253 | ||
| 2019-08-08 | NELSEN ROBERT Director | Other disposition | −400,000 | 10,668,749 | ||
| 2019-08-08 | NELSEN ROBERT Director | Other acquisition | +2,030 | 2,030 | ||
| 2019-05-30 | NELSEN ROBERT Director | Grant or award · Stock Option (right to buy) | +27,245 | 27,245 | ||
| 2018-06-13 | NELSEN ROBERT Director | Grant or award · Stock Option (right to buy) | +27,830 | 27,830 | ||
| 2017-12-12 | NELSEN ROBERT Director | Conversion | +10,756,249 | 11,068,749 | ||
| 2017-12-12 | NELSEN ROBERT Director | Conversion · Series A-1 Preferred Stock | −10,068,749 | 0 | ||
| 2017-12-12 | NELSEN ROBERT Director | Conversion · Series A-2 Preferred Stock | −375,000 | 0 | ||
| 2017-12-12 | NELSEN ROBERT Director | Conversion · Series B-1 Preferred Stock | −312,500 | 0 | ||
| 2017-12-07 | NELSEN ROBERT Director | Grant or award · Stock Option (right to buy) | +47,165 | 47,165 |
Page 1 of 1 · 19 trades